vs

Side-by-side financial comparison of Alignment Healthcare, Inc. (ALHC) and Privia Health Group, Inc. (PRVA). Click either name above to swap in a different company.

Alignment Healthcare, Inc. is the larger business by last-quarter revenue ($1.0B vs $541.2M, roughly 1.9× Privia Health Group, Inc.). Privia Health Group, Inc. runs the higher net margin — 1.7% vs -1.1%, a 2.8% gap on every dollar of revenue. On growth, Alignment Healthcare, Inc. posted the faster year-over-year revenue change (44.4% vs 17.4%). Over the past eight quarters, Alignment Healthcare, Inc.'s revenue compounded faster (26.9% CAGR vs 14.2%).

Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.

Privia Health Group, Inc. is a U.S.-headquartered healthcare technology and services firm supporting independent practices, health systems, and payers delivering value-based care. It offers population health tools, patient engagement platforms, care coordination support, and workflow solutions to boost patient outcomes and cut operational costs for U.S. healthcare stakeholders.

ALHC vs PRVA — Head-to-Head

Bigger by revenue
ALHC
ALHC
1.9× larger
ALHC
$1.0B
$541.2M
PRVA
Growing faster (revenue YoY)
ALHC
ALHC
+27.0% gap
ALHC
44.4%
17.4%
PRVA
Higher net margin
PRVA
PRVA
2.8% more per $
PRVA
1.7%
-1.1%
ALHC
Faster 2-yr revenue CAGR
ALHC
ALHC
Annualised
ALHC
26.9%
14.2%
PRVA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALHC
ALHC
PRVA
PRVA
Revenue
$1.0B
$541.2M
Net Profit
$-11.0M
$9.2M
Gross Margin
Operating Margin
-1.0%
2.1%
Net Margin
-1.1%
1.7%
Revenue YoY
44.4%
17.4%
Net Profit YoY
64.6%
108.0%
EPS (diluted)
$-0.04
$0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALHC
ALHC
PRVA
PRVA
Q4 25
$1.0B
$541.2M
Q3 25
$993.7M
$580.4M
Q2 25
$1.0B
$521.2M
Q1 25
$926.9M
$480.1M
Q4 24
$701.2M
$460.9M
Q3 24
$692.4M
$437.9M
Q2 24
$681.3M
$422.3M
Q1 24
$628.6M
$415.2M
Net Profit
ALHC
ALHC
PRVA
PRVA
Q4 25
$-11.0M
$9.2M
Q3 25
$3.7M
$6.9M
Q2 25
$15.7M
$2.7M
Q1 25
$-9.1M
$4.2M
Q4 24
$-31.1M
$4.4M
Q3 24
$-26.4M
$3.5M
Q2 24
$-24.0M
$3.5M
Q1 24
$-46.5M
$3.0M
Operating Margin
ALHC
ALHC
PRVA
PRVA
Q4 25
-1.0%
2.1%
Q3 25
0.8%
2.5%
Q2 25
2.2%
0.6%
Q1 25
-0.6%
1.1%
Q4 24
-3.2%
1.1%
Q3 24
-2.8%
1.3%
Q2 24
-2.7%
1.2%
Q1 24
-6.5%
0.2%
Net Margin
ALHC
ALHC
PRVA
PRVA
Q4 25
-1.1%
1.7%
Q3 25
0.4%
1.2%
Q2 25
1.5%
0.5%
Q1 25
-1.0%
0.9%
Q4 24
-4.4%
1.0%
Q3 24
-3.8%
0.8%
Q2 24
-3.5%
0.8%
Q1 24
-7.4%
0.7%
EPS (diluted)
ALHC
ALHC
PRVA
PRVA
Q4 25
$-0.04
$0.08
Q3 25
$0.02
$0.05
Q2 25
$0.07
$0.02
Q1 25
$-0.05
$0.03
Q4 24
$-0.15
$0.03
Q3 24
$-0.14
$0.03
Q2 24
$-0.13
$0.03
Q1 24
$-0.25
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALHC
ALHC
PRVA
PRVA
Cash + ST InvestmentsLiquidity on hand
$604.2M
$479.7M
Total DebtLower is stronger
$323.2M
Stockholders' EquityBook value
$179.3M
$737.2M
Total Assets
$1.1B
$1.4B
Debt / EquityLower = less leverage
1.80×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALHC
ALHC
PRVA
PRVA
Q4 25
$604.2M
$479.7M
Q3 25
$644.1M
$441.4M
Q2 25
$503.8M
$390.1M
Q1 25
$479.5M
$469.3M
Q4 24
$470.6M
$491.1M
Q3 24
$381.0M
$422.0M
Q2 24
$363.7M
$387.4M
Q1 24
$301.7M
$351.1M
Total Debt
ALHC
ALHC
PRVA
PRVA
Q4 25
$323.2M
Q3 25
$322.7M
Q2 25
$322.3M
Q1 25
$321.9M
Q4 24
$321.4M
Q3 24
$212.0M
Q2 24
$211.7M
Q1 24
$162.0M
Stockholders' Equity
ALHC
ALHC
PRVA
PRVA
Q4 25
$179.3M
$737.2M
Q3 25
$161.9M
$709.1M
Q2 25
$141.0M
$682.9M
Q1 25
$108.1M
$659.4M
Q4 24
$99.9M
$635.2M
Q3 24
$114.5M
$614.9M
Q2 24
$123.7M
$595.4M
Q1 24
$130.9M
$576.8M
Total Assets
ALHC
ALHC
PRVA
PRVA
Q4 25
$1.1B
$1.4B
Q3 25
$1.1B
$1.4B
Q2 25
$1.0B
$1.3B
Q1 25
$895.6M
$1.2B
Q4 24
$782.1M
$1.1B
Q3 24
$692.3M
$1.1B
Q2 24
$716.3M
$1.1B
Q1 24
$633.2M
$1.0B
Debt / Equity
ALHC
ALHC
PRVA
PRVA
Q4 25
1.80×
Q3 25
1.99×
Q2 25
2.29×
Q1 25
2.98×
Q4 24
3.22×
Q3 24
1.85×
Q2 24
1.71×
Q1 24
1.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALHC
ALHC
PRVA
PRVA
Operating Cash FlowLast quarter
$-50.4M
$127.5M
Free Cash FlowOCF − Capex
$-55.4M
FCF MarginFCF / Revenue
-5.5%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
13.93×
TTM Free Cash FlowTrailing 4 quarters
$113.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALHC
ALHC
PRVA
PRVA
Q4 25
$-50.4M
$127.5M
Q3 25
$144.6M
$52.0M
Q2 25
$29.1M
$8.0M
Q1 25
$16.6M
$-24.1M
Q4 24
$-8.7M
$74.8M
Q3 24
$26.2M
$33.2M
Q2 24
$23.5M
$34.5M
Q1 24
$-6.2M
$-33.1M
Free Cash Flow
ALHC
ALHC
PRVA
PRVA
Q4 25
$-55.4M
Q3 25
$139.1M
Q2 25
$21.1M
Q1 25
$8.4M
Q4 24
$-18.0M
Q3 24
$16.9M
Q2 24
$11.8M
Q1 24
$-17.4M
FCF Margin
ALHC
ALHC
PRVA
PRVA
Q4 25
-5.5%
Q3 25
14.0%
Q2 25
2.1%
Q1 25
0.9%
Q4 24
-2.6%
Q3 24
2.4%
Q2 24
1.7%
Q1 24
-2.8%
Capex Intensity
ALHC
ALHC
PRVA
PRVA
Q4 25
0.5%
Q3 25
0.6%
Q2 25
0.8%
Q1 25
0.9%
Q4 24
1.3%
Q3 24
1.3%
Q2 24
1.7%
Q1 24
1.8%
Cash Conversion
ALHC
ALHC
PRVA
PRVA
Q4 25
13.93×
Q3 25
38.77×
7.58×
Q2 25
1.86×
2.97×
Q1 25
-5.70×
Q4 24
17.00×
Q3 24
9.38×
Q2 24
9.94×
Q1 24
-11.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALHC
ALHC

Segment breakdown not available.

PRVA
PRVA

FFS Patient Care$364.4M67%
Capitated Revenue$71.4M13%
Shared Savings$46.9M9%
FFS Administrative Services$36.0M7%
Care Management Fee PMPM$20.0M4%
Other Revenue$2.5M0%

Related Comparisons